Association of sphingosine-1-phosphate (S1P)/S1P receptor-1 pathway with cell proliferation and survival in canine hemangiosarcoma

A. M. Rodriguez, A. J. Graef, D. N. LeVine, I. R. Cohen, J. F. Modiano, J. H. Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Sphingosine-1-phosphate (S1P) is a key biolipid signaling molecule that regulates cell growth and survival, but it has not been studied in tumors from dogs. Hypothesis/Objectives: S1P/S1P1 signaling will contribute to the progression of hemangiosarcoma (HSA). Animals: Thirteen spontaneous HSA tissues, 9 HSA cell lines, 8 nonmalignant tissues, including 6 splenic hematomas and 2 livers with vacuolar degeneration, and 1 endothelial cell line derived from a dog with splenic hematoma were used. Methods: This was a retrospective case series and in vitro study. Samples were obtained as part of medically necessary diagnostic procedures. Microarray, qRT-PCR, immunohistochemistry, and immunoblotting were performed to examine S1P1 expression. S1P concentrations were measured by high-performance liquid chromatography/mass spectrometry. S1P signaling was evaluated by intracellular Ca2+ mobilization; proliferation and survival were evaluated using the MTS assay and Annexin V staining. Results: Canine HSA cells expressed higher levels of S1P1 mRNA than nonmalignant endothelial cells. S1P1 protein was present in HSA tissues and cell lines. HSA cells appeared to produce low levels of S1P, but they selectively consumed S1P from the culture media. Exogenous S1P induced an increase in intracellular calcium as well as increased proliferation and viability of HSA cells. Prolonged treatment with FTY720, an inhibitor of S1P1, decreased S1P1 protein expression and induced apoptosis of HSA cells. Conclusions and clinical importance: S1P/S1P1 signaling pathway functions to maintain HSA cell viability and proliferation. The data suggest that S1P1 or the S1P pathway in general could be targets for therapeutic intervention for dogs with HSA.

Original languageEnglish (US)
Pages (from-to)1088-1097
Number of pages10
JournalJournal of veterinary internal medicine
Volume29
Issue number4
DOIs
StatePublished - Jan 1 2015

Fingerprint

Lysosphingolipid Receptors
sphingosine
hemangiosarcoma
Hemangiosarcoma
cell viability
Canidae
cell proliferation
Cell Survival
Cell Proliferation
phosphates
receptors
dogs
hematoma
cell lines
Dogs
Cell Line
Hematoma
endothelial cells
Endothelial Cells
sphingosine 1-phosphate

Keywords

  • Cancer
  • Dogs, FTY720
  • Signal transduction
  • Vascular cells

Cite this

Association of sphingosine-1-phosphate (S1P)/S1P receptor-1 pathway with cell proliferation and survival in canine hemangiosarcoma. / Rodriguez, A. M.; Graef, A. J.; LeVine, D. N.; Cohen, I. R.; Modiano, J. F.; Kim, J. H.

In: Journal of veterinary internal medicine, Vol. 29, No. 4, 01.01.2015, p. 1088-1097.

Research output: Contribution to journalArticle

@article{0be23345724a44f9bdec340084fc1114,
title = "Association of sphingosine-1-phosphate (S1P)/S1P receptor-1 pathway with cell proliferation and survival in canine hemangiosarcoma",
abstract = "Background: Sphingosine-1-phosphate (S1P) is a key biolipid signaling molecule that regulates cell growth and survival, but it has not been studied in tumors from dogs. Hypothesis/Objectives: S1P/S1P1 signaling will contribute to the progression of hemangiosarcoma (HSA). Animals: Thirteen spontaneous HSA tissues, 9 HSA cell lines, 8 nonmalignant tissues, including 6 splenic hematomas and 2 livers with vacuolar degeneration, and 1 endothelial cell line derived from a dog with splenic hematoma were used. Methods: This was a retrospective case series and in vitro study. Samples were obtained as part of medically necessary diagnostic procedures. Microarray, qRT-PCR, immunohistochemistry, and immunoblotting were performed to examine S1P1 expression. S1P concentrations were measured by high-performance liquid chromatography/mass spectrometry. S1P signaling was evaluated by intracellular Ca2+ mobilization; proliferation and survival were evaluated using the MTS assay and Annexin V staining. Results: Canine HSA cells expressed higher levels of S1P1 mRNA than nonmalignant endothelial cells. S1P1 protein was present in HSA tissues and cell lines. HSA cells appeared to produce low levels of S1P, but they selectively consumed S1P from the culture media. Exogenous S1P induced an increase in intracellular calcium as well as increased proliferation and viability of HSA cells. Prolonged treatment with FTY720, an inhibitor of S1P1, decreased S1P1 protein expression and induced apoptosis of HSA cells. Conclusions and clinical importance: S1P/S1P1 signaling pathway functions to maintain HSA cell viability and proliferation. The data suggest that S1P1 or the S1P pathway in general could be targets for therapeutic intervention for dogs with HSA.",
keywords = "Cancer, Dogs, FTY720, Signal transduction, Vascular cells",
author = "Rodriguez, {A. M.} and Graef, {A. J.} and LeVine, {D. N.} and Cohen, {I. R.} and Modiano, {J. F.} and Kim, {J. H.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1111/jvim.13570",
language = "English (US)",
volume = "29",
pages = "1088--1097",
journal = "Journal of Veterinary Internal Medicine",
issn = "0891-6640",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Association of sphingosine-1-phosphate (S1P)/S1P receptor-1 pathway with cell proliferation and survival in canine hemangiosarcoma

AU - Rodriguez, A. M.

AU - Graef, A. J.

AU - LeVine, D. N.

AU - Cohen, I. R.

AU - Modiano, J. F.

AU - Kim, J. H.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background: Sphingosine-1-phosphate (S1P) is a key biolipid signaling molecule that regulates cell growth and survival, but it has not been studied in tumors from dogs. Hypothesis/Objectives: S1P/S1P1 signaling will contribute to the progression of hemangiosarcoma (HSA). Animals: Thirteen spontaneous HSA tissues, 9 HSA cell lines, 8 nonmalignant tissues, including 6 splenic hematomas and 2 livers with vacuolar degeneration, and 1 endothelial cell line derived from a dog with splenic hematoma were used. Methods: This was a retrospective case series and in vitro study. Samples were obtained as part of medically necessary diagnostic procedures. Microarray, qRT-PCR, immunohistochemistry, and immunoblotting were performed to examine S1P1 expression. S1P concentrations were measured by high-performance liquid chromatography/mass spectrometry. S1P signaling was evaluated by intracellular Ca2+ mobilization; proliferation and survival were evaluated using the MTS assay and Annexin V staining. Results: Canine HSA cells expressed higher levels of S1P1 mRNA than nonmalignant endothelial cells. S1P1 protein was present in HSA tissues and cell lines. HSA cells appeared to produce low levels of S1P, but they selectively consumed S1P from the culture media. Exogenous S1P induced an increase in intracellular calcium as well as increased proliferation and viability of HSA cells. Prolonged treatment with FTY720, an inhibitor of S1P1, decreased S1P1 protein expression and induced apoptosis of HSA cells. Conclusions and clinical importance: S1P/S1P1 signaling pathway functions to maintain HSA cell viability and proliferation. The data suggest that S1P1 or the S1P pathway in general could be targets for therapeutic intervention for dogs with HSA.

AB - Background: Sphingosine-1-phosphate (S1P) is a key biolipid signaling molecule that regulates cell growth and survival, but it has not been studied in tumors from dogs. Hypothesis/Objectives: S1P/S1P1 signaling will contribute to the progression of hemangiosarcoma (HSA). Animals: Thirteen spontaneous HSA tissues, 9 HSA cell lines, 8 nonmalignant tissues, including 6 splenic hematomas and 2 livers with vacuolar degeneration, and 1 endothelial cell line derived from a dog with splenic hematoma were used. Methods: This was a retrospective case series and in vitro study. Samples were obtained as part of medically necessary diagnostic procedures. Microarray, qRT-PCR, immunohistochemistry, and immunoblotting were performed to examine S1P1 expression. S1P concentrations were measured by high-performance liquid chromatography/mass spectrometry. S1P signaling was evaluated by intracellular Ca2+ mobilization; proliferation and survival were evaluated using the MTS assay and Annexin V staining. Results: Canine HSA cells expressed higher levels of S1P1 mRNA than nonmalignant endothelial cells. S1P1 protein was present in HSA tissues and cell lines. HSA cells appeared to produce low levels of S1P, but they selectively consumed S1P from the culture media. Exogenous S1P induced an increase in intracellular calcium as well as increased proliferation and viability of HSA cells. Prolonged treatment with FTY720, an inhibitor of S1P1, decreased S1P1 protein expression and induced apoptosis of HSA cells. Conclusions and clinical importance: S1P/S1P1 signaling pathway functions to maintain HSA cell viability and proliferation. The data suggest that S1P1 or the S1P pathway in general could be targets for therapeutic intervention for dogs with HSA.

KW - Cancer

KW - Dogs, FTY720

KW - Signal transduction

KW - Vascular cells

UR - http://www.scopus.com/inward/record.url?scp=84943361027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943361027&partnerID=8YFLogxK

U2 - 10.1111/jvim.13570

DO - 10.1111/jvim.13570

M3 - Article

VL - 29

SP - 1088

EP - 1097

JO - Journal of Veterinary Internal Medicine

JF - Journal of Veterinary Internal Medicine

SN - 0891-6640

IS - 4

ER -